Invention Application
- Patent Title: CHIMPANZEE ADENOVIRUS CONSTRUCTS WITH LYSSAVIRUS ANTIGENS
-
Application No.: US16467569Application Date: 2017-12-08
-
Publication No.: US20220112245A2Publication Date: 2022-04-14
- Inventor: Virginia AMMENDOLA , Stefano COLLOCA , Alessandra VITELLI , Benjamin WIZEL
- Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
- Applicant Address: BE RIXENSART
- Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
- Current Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
- Current Assignee Address: BE RIXENSART
- International Application: PCT/IB2017/057759 WO 20171208
- Main IPC: C07K14/005
- IPC: C07K14/005 ; A61K39/39 ; A61K39/205 ; C12N15/86 ; A61P31/14 ; A61K39/21 ; A61P31/18 ; A61K39/12
Abstract:
The invention provides adenoviral vectors comprising transgenes encoding Lyssaviral antigens. The vectors can be used to produce vaccines for the prophylaxis, amelioration and treatment of diseases caused by Lyssaviral diseases, e.g., rabies.
Public/Granted literature
- US20210269486A1 CHIMPANZEE ADENOVIRUS CONSTRUCTS WITH LYSSAVIRUS ANTIGENS Public/Granted day:2021-09-02
Information query
